Company / Net Income
Tempest Therapeutics, Inc. Net Income History
FY2015-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$73.2M
FY2017
5-year range
-$73.2M / -$29.0M
FY2015-FY2017
Trend
-47.9%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$29M to -$73M over the past 2 years.
Based on SEC 10-K filings.
-$73M in FY2017.
Declined from -$29M to -$73M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, net income decreased 47.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | -$73.2M | -47.9% |
| FY2016 | -$49.5M | -70.5% |
| FY2015 | -$29.0M | - |
As of FY2017 · SEC 10-K · Updated Jun 28, 2026